ArticleScientific reports2025
Clinical prediction study on the risk of atrial fibrillation in hypertensive patients based on metabolism, inflammation, and gender differences.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dynamic prediction of paroxysmal atrial fibrillation onset using longitudinal sample entropy in joint models.BMC medical research methodology · 2026Article
- Triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2026Review
- Lipoprotein(a) and Atrial Fibrillation: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2025Review
- The Triglyceride-Glucose Index: A Clinical Tool to Quantify Insulin Resistance as a Metabolic Myocardial Remodeling Bridge in Atrial Fibrillation.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore the risk factors for atrial fibrillation (AF) within one year after discharge in hypertensive patients and to construct a corresponding predictive model. This single-center, retrospective study included 566 patients admitted with hypertension. Patients were divided into two groups: those who developed AF within one year after discharge and those who did not. Variables were selected for multivariate regression analysis using univariate regression and variance inflation factor (VIF) analysis. Subgroup analysis was performed by gender to explore the predictive value of the variables, and a nomogram was constructed. The total sample was randomly divided into a training set and a validation set (7:3 ratio). The discrimination and calibration of the predictive model were evaluated using receiver operating characteristic (ROC) and calibration curves. Patients who developed AF within one year had significantly higher levels of white blood cells (WBC), neutrophils (NEUT), lymphocytes (LYMPH), creatinine (Scr), fasting blood glucose (FBG), triglycerides (TG), lipoprotein(a) [Lp(a)], glycated hemoglobin (HbA1c), neutrophil-to-lymphocyte ratio (NLR), and triglyceride-glucose (TyG) index compared to those who did not (P < 0.05). Males, smokers, and diabetic patients were more prevalent in the AF group (P < 0.05). Logistic regression analysis showed that male gender, Lp(a), HbA1c, NLR, and the TyG index were independent predictors of AF within one year after discharge in hypertensive patients. The nomogram constructed showed an area under the ROC curve (AUC) of 0.793 in the training set and 0.740 in the validation set. The calibration curves indicated good fit (P = 0.726 in the training set; P = 0.489 in the validation set). Male, Lp(a), HbA1c, NLR, and the TyG index are independent risk factors for AF within one year of discharge in hypertensive patients. The nomogram model constructed has high predictive accuracy. This study suggests that individualized management strategies should be employed based on these risk factors in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.